LiverMultiScan shown to be a cost-effective alternative to liver biopsies for monitoring patients with autoimmune hepatitis
September 21, 2022
FDA Grants Clearance to Perspectum’s CoverScan – A New Platform-Based Tool to Assess Multiple Organs in One MRI Scan
May 22, 2022
LiverMultiScan® detected earlier stages of treatable disease in patients with autoimmune hepatitis to allow tailored treatment
March 21, 2022
LiverMultiScan® has achieved nationwide payer coverage for diagnosis and management of NAFLD and other established chronic liver diseases
March 14, 2022
First patient recruited for multi-year collaborative primary sclerosing cholangitis (PSC) pediatric study using Perspectum’s imaging technology to help predict disease progression and guide patient management
January 27, 2022
New meta-analysis finds Perspectum’s non-invasive MRI biomarker cT1 is an effective alternative to biopsy for identifying patients at high risk of liver disease progression
January 12, 2022
Perspectum and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health
November 1, 2021
Perspectum Expands into Louisiana in Partnership with West Jefferson Medical Center in New Orleans, LA
October 5, 2021
Perspectum Announces Partnership with Datavant to Improve Clinical Trial Recruitment with Connected Data
September 16, 2021
